Samuli Eldfors

Samuli Eldfors

UNVERIFIED PROFILE

Are you Samuli Eldfors?   Register this Author

Register author
Samuli Eldfors

Samuli Eldfors

Publications by authors named "Samuli Eldfors"

Are you Samuli Eldfors?   Register this Author

16Publications

598Reads

8Profile Views

Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study.

Int J Cancer 2019 07 7;145(1):87-98. Epub 2019 Jan 7.

Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32085DOI Listing
July 2019

Dasatinib and navitoclax act synergistically to target NUP98-NSD1/FLT3-ITD acute myeloid leukemia.

Leukemia 2019 06 19;33(6):1360-1372. Epub 2018 Dec 19.

Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0327-2DOI Listing
June 2019

Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas.

Gynecol Oncol 2018 07 30;150(1):92-98. Epub 2018 Apr 30.

Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.04.566DOI Listing
July 2018

Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations.

Oncotarget 2017 Dec 14;8(64):108020-108030. Epub 2017 Nov 14.

Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746122PMC
December 2017

Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing.

Exp Dermatol 2014 May;23(5):366-8

Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/exd.12405
Publisher Site
http://dx.doi.org/10.1111/exd.12405DOI Listing
May 2014

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Cancer Discov 2013 Dec 20;3(12):1416-29. Epub 2013 Sep 20.

1Institute for Molecular Medicine Finland, FIMM; 2Hematology Research Unit Helsinki, Helsinki University Central Hospital, University of Helsinki, Helsinki; 3Department of Clinical Chemistry and TYKSLAB, Turku University Central Hospital, University of Turku, Turku; 4Department of Internal Medicine, Tampere University Hospital, Tampere, Finland; 5Department of Clinical Science, Hematology Section, University of Bergen; and 6Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0350DOI Listing
December 2013

Comparison of solution-based exome capture methods for next generation sequencing.

Genome Biol 2011 Sep 28;12(9):R94. Epub 2011 Sep 28.

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Biomedicum Helsinki 2U, Tukholmankatu 8, 00290 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gb-2011-12-9-r94DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308057PMC
September 2011